Showing results (1401-1410 of 2,098) with videos related to

Sort By:
Pageof 210
Cancer Cell International|November 13, 2021
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world studyYa-Nan Jin, Meng-Yun Qiang, Meng-Meng Liu, et al.
Antioxidants (Basel, Switzerland)|October 23, 2021
Comprehensive Analysis of Secondary Metabolites in the Extracts from Different Lily Bulbs and Their Antioxidant AbilityYu-Chao Tang, Yi-Jie Liu, Guo-Ren He, et al.
The Analyst|May 30, 2019
Improving quantitative control and homogeneous distribution of samples on paper-based analytical devices via drop-on-demand inkjet printingMeng-Meng Liu, Xin Lian, Zi-Zhen Guo, et al.
Journal of Oncology|August 11, 2020
Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-<i>κ</i>B (P65) Pathway in Hepatocellular Carcinoma CellsQiu-Ting Li, Meng-Jun Qiu, Sheng-Li Yang, et al.
BMC Pharmacology & Toxicology|February 28, 2023
Protective effects of pentoxifylline against chlorine-induced acute lung injury in ratsMeng-Meng Liu, Jiang-Zheng Liu, Chen-Qian Zhao, et al.
Journal of Hepatology|May 15, 2020
Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinomaZhi-Peng Peng, Ze-Zhou Jiang, Hao-Fan Guo, et al.
Lipids in Health and Disease|October 14, 2025
Exploring the relationship between residual cholesterol, body mass index, and hypertension risk: a national cohort studyTian-Qi Teng, Jing Liu, Meng-Meng Wang, et al.
Signal Transduction and Targeted Therapy|July 27, 2025
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06)Yi-Ge Shen, Qing Shi, Wei Tang, et al.
Clinical Laboratory|July 15, 2025
Expression and Clinical Significance of PIM1 in Newly Diagnosed Patients with Acute Myeloid LeukemiaZhong-Yu Li, Yuan-Yuan Tan, Meng-Meng Zhang, et al.
Cancer Letters|February 28, 2025
A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatmentRui Fu, Chao Zhang, Meng-Meng Song, et al.
Pageof 210